middle.news
How Chimeric Therapeutics Secured $1.8M to Fuel Cancer Trials
10:22am on Monday 2nd of March, 2026 AEDT
•
Healthcare
Read Story
How Chimeric Therapeutics Secured $1.8M to Fuel Cancer Trials
10:22am on Monday 2nd of March, 2026 AEDT
Key Points
Secured $1.785 million advance from Radium Capital
Funding backed by anticipated FY26 R&D Tax Incentive
Supports clinical trials and general working capital
Repayment due by 31 December 2026 with commercial interest
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CHIMERIC THERAPEUTICS (ASX:CHM)
OPEN ARTICLE